English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduModerate alcohol use does not reduce cardiometabolic disease risk among veterans of European, African, or Hispanic ancestry, a new study suggests. The findings add to growing evidence that traditional research methods applied to drinking levels and certain disease outcomes have created illusory and misleading results. Heavy drinking is known to be linked to coronary heart disease (CHD) and type 2 diabetes (T2D). Traditional observational studies have, however, associated moderate drinking with the lowest risk and abstinence with a moderate risk (the U-curve or J-curve effect). In recent years, the U-curve has been increasingly attributed to confounding errors—when study results are distorted by other factors. In this case, the abstinence category is implicated since it establishes a false equivalence between study participants with widely differing risk factors (lifelong non-drinkers, those who stopped drinking for health or other alcohol-related problems, and those who falsely reporte
Tag: cardiometabolic disease
Moderate coffee and caffeine consumption is associated with lower risk of developing multiple cardiometabolic diseases, new study finds
Consuming moderate amounts of coffee and caffeine regularly may offer a protective effect against developing multiple cardiometabolic diseases, including type 2 diabetes, coronary heart disease and stroke, according to new research published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
Mount Sinai Experts to Present New Research on Long COVID, Lung Cancer, Asthma, Sleep Apnea, and More at ATS 2024 International Conference
Available for interview on breaking news, trending topics in respiratory medicine
UAH Nursing researcher to study cardiometabolic disease among Black women in the Deep South
A researcher at The University of Alabama in Huntsville (UAH) has been awarded a $179,000 subcontract to explore community-based strategies for reducing high-burden chronic disease like obesity, diabetes, heart disease and cancer as part of an overall award totaling $4.2 million.
Globally, Consumption of Sugary Drinks Increased at Least 16% Since 1990
The decision to reach for a sugar sweetened beverage is heavily influenced by where you live, Tufts University researchers report in a new study that provides a snapshot of how adults in 185 countries imbibe sugar-sweetened beverages.
UCSF Internal Medicine Specialist to be Celebrated for Diabetes Epidemiology Research
Alka M. Kanaya, MD, UC San Francisco primary care physician and researcher, is being recognized with the 2023 Kelly West Award for Outstanding Achievement in Epidemiology from the American Diabetes Association (ADA). The award recognizes significant contributions to the field of diabetes epidemiology.
Biases in cardiometabolic research put minority women’s lives at risk
Biases in heart disease and metabolic disorder—also known as cardiometabolic—studies are putting the lives of midlife Black and Hispanic women in jeopardy.
Eating Whole Grains Linked to Smaller Increases in Waist Size, Blood Pressure, Blood Sugar
A study finds middle- to older-aged adults who ate more servings of whole grains, compared to those who ate fewer, were more likely to have smaller increases in waist size, blood pressure, and blood sugar levels as they aged. All three are linked with increased risk of heart disease.
Wayne State University and Henry Ford Health System announce new initiative in cardiometabolic health and disease
Wayne State University and Henry Ford Health System announced today the launch of a basic and translational research initiative in Cardiometabolic Health and Disease as a thematic focus for program growth.
A Novel Monoclonal Antibody Therapy Cuts LDL Cholesterol by Half in a High-Risk Patient Population, Study Shows
The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol—the so-called “bad” cholesterol—by 50 percent in patients with severe hypercholesterolemia whose condition is resistant to standard treatments, a phase 2 study from the Icahn School of Medicine of Mount Sinai and other global academic sites has found.